Conférence de l’Association pour le Traitement de la Dépendance aux Opiacés de 2015


Conférence de l’Association pour le Traitement de la Dépendance aux Opiacés de 2015

26 novembre 2014

La conférence présentera les dernières données scientifiques sur le traitement de la dépendance aux opiacés et sur le développement de stratégies pour soutenir les partenariats dans le domaine de la santé et les efforts de collaboration avec les partenaires communautaires. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.

Abonnez-vous à l'Alerte mensuelle de l'IDPC pour recevoir des informations relatives à la politique des drogues.

The American Association for the Treatment of Opioid Dependence works with federal agencies and state substance abuse authorities concerning opioid treatment policy. The Association developed the State Methadone Guidelines (1993) and conjunction with the American Society of Addiction Medicine (ASAM) for the Center for Substance Abuse Treatment (CSAT).

The Association convenes national conferences on an eighteen-month cycle. These conferences focus on evidence-based clinical practice, current research breakthroughs and organizational developments affecting the current and future opioid treatment system. More than 46 states and 21 countries send representatives to this event. The National Institute on Drug Abuse (NIDA) in addition to SAMHSA/ CSAT and other federal agencies work to support a number of the activities of this conference, including international relations and domestic substance abuse policy. The State Opioid Treatment Authorities meet during this event, working through policy related issues in their respective states.

The 2015 conference in Atlanta aims:

  • To present the latest evidence relevant to the field and critically evaluate the implications for patients, clinicians, administrators, and policy makers
  • To disseminate evaluation and treatment techniques to better serve patients and providers, improve program development and administration, and enhance patient outcomes
  • To develop strategies to assist healthcare partnerships and collaborations by advancing their understanding of medication assisted treatment as a crucial element to community wellness in an era of healthcare reform
  • To improve the collaboration between opioid treatment programs and community partners in response to the heightened risks associated with the use of opioids
  • To formulate methods to promote, support, facilitate, and integrate medication assisted treatment into the judicial and penal systems, government, and social service organizations
  • To discuss the magnitude and impact of prescription opioids on the healthcare system and Opioid Treatment Programs

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.

Atlanta, Etats-Unis
Commencez27 mars 2015
Fin31 mars 2015